Suzanne M. Aarts
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Adipocytes control hematopoiesis and inflammation through CD40 signaling.
Journal: Haematologica
Published: May 30, 2022
Myeloid CD40 deficiency reduces atherosclerosis by impairing macrophages' transition into a pro-inflammatory state.
Journal: Cardiovascular research
Published: February 16, 2022
Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
Journal: The American journal of clinical nutrition
Published: October 25, 2019
Deficiency of T cell CD40L has minor beneficial effects on obesity-induced metabolic dysfunction.
Journal: BMJ open diabetes research & care
Published: August 15, 2019
Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.
Journal: PloS one
Published: May 08, 2018
The CD40-CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Journal: Frontiers in immunology
Published: September 06, 2017
Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.
Journal: Journal of the American College of Cardiology
Published: April 24, 2017
Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.
Journal: Journal of neuroinflammation
Published: December 16, 2016
Cathelicidin regulates myeloid cell accumulation in adipose tissue and promotes insulin resistance during obesity.
Journal: Thrombosis and haemostasis
Published: February 11, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026